OI
OsteoGeneX, Inc
osteogenex.com
Website unreachable since Oct 18, 2026
This company develops a small molecule drug that inhibits sclerostin, a protein that inhibits bone formation. By blocking sclerostin, the drug aims to stimulate bone growth and increase bone density in patients with bone-related disorders.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops a small molecule drug that inhibits sclerostin, a protein that inhibits bone formation. By blocking sclerostin, the drug aims to stimulate bone growth and increase bone density in patients with bone-related disorders.